Edwards Lifesciences makes replacement heart valves implanted without open-heart surgery.
Edwards Lifesciences Corporation (EW) is expected to report earnings on Wednesday, November 4, 2026, after the close. Estimated release time 16:23 ET. Consensus EPS estimate is $0.74.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-23 | Jun 2026 qtr | $0.74 | $0.78 | +5.0% | $1.74B |
| 2026-04-23 | Mar 2026 qtr | $0.73 | $0.66 | -9.5% | $1.65B |
| 2026-02-10 | Dec 2025 qtr | $0.62 | $0.16 | — | $1.57B |
| 2025-10-30 | Sep 2025 qtr | $0.60 | $0.50 | — | $1.55B |
| 2025-07-24 | Jun 2025 qtr | $0.62 | $0.57 | -8.7% | $1.53B |
| 2025-04-23 | Mar 2025 qtr | $0.60 | $0.61 | +2.3% | $1.41B |
| 2025-02-11 | Dec 2024 qtr | $0.55 | $0.65 | — | $1.39B |
| 2024-07-24 | Jun 2024 qtr | $0.69 | $0.61 | -11.6% | $1.39B |
EW has beaten consensus EPS in 2 of its last 5 scored quarters.
See EW on the live calendar →